Mar 15, 2022 8:00 am EDT Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Mar 14, 2022 8:00 am EDT Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors
Mar 11, 2022 8:00 am EST Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award
Mar 10, 2022 8:00 am EST Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update
Feb 24, 2022 8:00 am EST Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022
Feb 3, 2022 8:00 am EST Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Award
Feb 2, 2022 8:00 am EST Achieve Life Sciences Announces Participation in February Investor Conferences
Jan 25, 2022 8:00 am EST Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
Jan 6, 2022 8:30 am EST Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference